✦ LIBER ✦

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

✍ Scribed by Tillmanns, Todd D.; Lowe, M. Patrick; Walker, Mark S.; Stepanski, Edward J.; Schwartzberg, Lee S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of imatinib mesylate in p

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase I study of intraperitoneal carbo

✍ O’Malley, D.; Eisenhauer, E.; McCann, G.; Salani, R.; Backes, F.; Copeland, L.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A phase II clinical trial of pegylated l

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Phase II trial of lapatinib and topoteca

✍ S. John Weroha; Ann L. Oberg; Katie L. Allen Ziegler; Shaker R. Dakhilm; Kendrit 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

A phase II trial of weekly docetaxel in

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II Trial of Bevacizumab in Persist

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB